91-105 of 183
Improving CKD Patient Outcomes with SGLT2 Inhibitors
Clinician's RoundtableImproving CKD Patient Outcomes with SGLT2 Inhibitors
Gates B. Colbert, MD
Improving CKD Awareness: Emphasizing the Risk in Patients Who Are Unaware
Clinician's RoundtableImproving CKD Awareness: Emphasizing the Risk in Patients Who Are Unaware
Ashley Baker, MSN, PMHNP
Chi D. Chu, MD, MAS
ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
Project Oncology®ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
Jessica E. Hawley M.D. M.S.
Key Tests That Play a Crucial Role in Accurately Diagnosing GU Cancers
Project Oncology®Key Tests That Play a Crucial Role in Accurately Diagnosing GU Cancers
Addressing Health Equity in Genitourinary Cancer Clinical Trials
Project Oncology®Addressing Health Equity in Genitourinary Cancer Clinical Trials
AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD
Heart MattersAHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD
Javed Butler, MD
Chiadi Ndumele, M.D., Ph.D., M.H.S.
- advertisement
CKM Syndrome Linked to Heart, Kidney, and Metabolic Diseases
Heart MattersCKM Syndrome Linked to Heart, Kidney, and Metabolic Diseases
Recapping a Narrative Review on the Management of Chronic Kidney Disease in T2D
Diabetes DiscourseRecapping a Narrative Review on the Management of Chronic Kidney Disease in T2D
John Buse, MD, PhD
David Cherney, MD, PhD
Peter Lin MD, CCFP
Sri Lekha Tummalapalli, MD, MBA, MAS
Peter Lin MD, CCFP
Magdalena Madero, MD
Peter Lin MD, CCFP
Joel Topf, MD
Appropriate CKD Referral to Specialists
KDIGO Conversations in NephrologyAppropriate CKD Referral to Specialists
Peter Lin MD, CCFP
Ikechi Okpechi
- advertisement
Identifying Unmet Needs in the Management of Glomerular Diseases
Clinician's RoundtableIdentifying Unmet Needs in the Management of Glomerular Diseases
Frank Cortazar, MD
Challenging Common Misconceptions About IgAN
Clinician's RoundtableChallenging Common Misconceptions About IgAN
Frank Cortazar, MD
Understanding the Role of the Complement Pathways in IgAN
Clinician's RoundtableUnderstanding the Role of the Complement Pathways in IgAN
Charles Turck, PharmD, BCPS, BCCCP
Carl P. Walther, MD